ECSP109981A - Composiciones de liposomas para administración in vivo de compuestos de ácido borónico - Google Patents

Composiciones de liposomas para administración in vivo de compuestos de ácido borónico

Info

Publication number
ECSP109981A
ECSP109981A EC2010009981A ECSP109981A ECSP109981A EC SP109981 A ECSP109981 A EC SP109981A EC 2010009981 A EC2010009981 A EC 2010009981A EC SP109981 A ECSP109981 A EC SP109981A EC SP109981 A ECSP109981 A EC SP109981A
Authority
EC
Ecuador
Prior art keywords
boronic acid
liposomes
compositions
acid compounds
vivo administration
Prior art date
Application number
EC2010009981A
Other languages
English (en)
Inventor
Anthony Huang
Bing Luo
Jinkang Wang
Yuanpeng Zhang
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ECSP109981A publication Critical patent/ECSP109981A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen formulaciones de liposomas para la administración de un compuesto de ácido borónico. Los liposomas comprenden un fosfolípido que tiene dos cadenas de acilo con 20 a 22 átomos de carbono en cada cadena y un compuesto de ácido borónico atrapado en los liposomas. En una modalidad preferida, el compuesto de ácido borónico se presenta en forma de un complejo con meglumina.
EC2010009981A 2007-08-21 2010-02-22 Composiciones de liposomas para administración in vivo de compuestos de ácido borónico ECSP109981A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95704507P 2007-08-21 2007-08-21

Publications (1)

Publication Number Publication Date
ECSP109981A true ECSP109981A (es) 2010-04-30

Family

ID=39772942

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010009981A ECSP109981A (es) 2007-08-21 2010-02-22 Composiciones de liposomas para administración in vivo de compuestos de ácido borónico

Country Status (13)

Country Link
US (1) US20090092661A1 (es)
EP (1) EP2190411A2 (es)
JP (1) JP2010536874A (es)
KR (1) KR20100095507A (es)
CN (1) CN101795671A (es)
AU (1) AU2008288917A1 (es)
BR (1) BRPI0815613A2 (es)
CA (1) CA2697042A1 (es)
CO (1) CO6260056A2 (es)
EA (1) EA201070296A1 (es)
EC (1) ECSP109981A (es)
MX (1) MX2010002100A (es)
WO (1) WO2009026427A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110114562A (ko) 2009-01-09 2011-10-19 썬 파마 어드밴스트 리서치 컴패니 리미티드 보르테조밉 함유 약학적 조성물
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US8263578B2 (en) 2010-03-18 2012-09-11 Innopharma, Inc. Stable bortezomib formulations
RU2529800C2 (ru) * 2010-03-18 2014-09-27 ИННОФАРМА, Инк. Стабильные составы бортезомиба
GB201020860D0 (en) * 2010-12-09 2011-01-26 Univ Wolverhampton Disulfiram formulation and uses thereof
EP2787977A4 (en) * 2011-12-09 2015-05-06 Univ California LIPOSOMAL ACTIVE INVERTING
AU2013227219A1 (en) * 2012-03-02 2014-10-23 Dr. Reddy's Laboratories Limited Pharmaceutical compositions comprising boronic acid compounds
WO2014015027A1 (en) * 2012-07-18 2014-01-23 Onyx Therapeutics, Inc. Liposomal compositions of epoxyketone-based proteasome inhibitors
KR102310786B1 (ko) 2013-02-01 2021-10-12 존원 파마, 인코포레이티드 리포좀 내로 난수용성 약물의 원격 부하
CN103142509B (zh) * 2013-03-06 2018-01-02 石药集团中奇制药技术（石家庄）有限公司 一种注射用硼替佐米药物组合物
MA38687A1 (fr) 2013-05-30 2017-12-29 Nanobiotix Composition pharmaceutique, préparation et utilisations de celle-ci
CN106132970B (zh) * 2014-02-03 2020-09-04 俄亥俄州创新基金会 硼酸酯和其药物制剂
CN106999419A (zh) 2014-08-04 2017-08-01 佐尼奥尼制药股份有限公司 远程装载略微水溶性药物至脂质膜泡
PT3229776T (pt) 2014-11-25 2023-08-17 Curadigm Sas Composição farmacêutica combinando pelo menos duas nanopartícuas distintas e um composto farmacêutico, preparaçâo e suas utilizações
DK3223796T3 (da) 2014-11-25 2021-09-27 Curadigm Sas Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
AU2015352685B2 (en) * 2014-11-25 2020-09-17 Nanobiotix Pharmaceutical composition, preparation and uses thereof
WO2016171446A1 (ko) * 2015-04-20 2016-10-27 동아에스티 주식회사 펩타이드 붕소산 화합물을 함유하는 안정화 약학 제제
JP2018516256A (ja) 2015-05-28 2018-06-21 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 治療用ワクチンとしての使用のためのナノ粒子
CN106265536B (zh) * 2016-08-24 2019-01-11 江苏豪森药业集团有限公司 硼替佐米药物组合物及其制备方法
CN109045272A (zh) * 2018-08-01 2018-12-21 厦门市壳聚糖生物科技有限公司 一种硼替佐米磷脂复合物及其制备方法与应用
CN112915094A (zh) * 2021-03-26 2021-06-08 东南大学 一种硼替佐米脂质体制剂的制备方法
WO2024067849A1 (zh) * 2022-09-30 2024-04-04 上海济煜医药科技有限公司 一种脂质体药物组合物及其制备方法和应用
WO2024067840A1 (zh) * 2022-09-30 2024-04-04 上海济煜医药科技有限公司 一种脂质体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661044A1 (en) * 1991-07-03 1995-07-05 NeXstar Pharmaceuticals, Inc. Drug-containing liposomes
EP0825852B1 (en) * 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
US7351427B2 (en) * 1998-06-18 2008-04-01 Busulipo Ab Pharmaceutical composition, a method of preparing it and a method of treatment by use thereof
AU2001258106A1 (en) * 2000-05-11 2001-11-20 Celator Technologies Inc. Lipid carrier compositions for improved drug retention
DE60305113T2 (de) * 2002-09-09 2006-12-07 Trigen Ltd. Borsäuresalze und deren Verwendung in der Bereitstellung von Medikamente für die Thrombosebehandlung
TW200618820A (en) * 2004-11-05 2006-06-16 Alza Corp Liposome formulations of boronic acid compounds

Also Published As

Publication number Publication date
MX2010002100A (es) 2010-03-26
US20090092661A1 (en) 2009-04-09
EA201070296A1 (ru) 2010-08-30
CO6260056A2 (es) 2011-03-22
AU2008288917A1 (en) 2009-02-26
JP2010536874A (ja) 2010-12-02
KR20100095507A (ko) 2010-08-31
WO2009026427A2 (en) 2009-02-26
CN101795671A (zh) 2010-08-04
CA2697042A1 (en) 2009-02-26
EP2190411A2 (en) 2010-06-02
WO2009026427A3 (en) 2009-09-24
BRPI0815613A2 (pt) 2015-03-24

Similar Documents

Publication Publication Date Title
MX2010002100A (es) Composiciones de liposomas para administracion in vivo de compuestos de acido boronico.
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
MX2009004203A (es) Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
CR9587A (es) Derivados de piridazina
CY1114759T1 (el) Παραγωγα πυριδιν-4-υλι0υ ως s1p1/edg1 αγωνιστες
NI201000041A (es) Derivados y composiciones que comprenden quinazolinona 6-, 7-, u 8 - sustituida y métodos para utilizar la misma.
UY28955A1 (es) Nuevos derivados fluoroglicosídicos de pirazoles, medicamentos que contienen estos compuestos, y el empleo de los mismos
PA8592301A1 (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
CR9703A (es) Derivados de pirazolona
UY29191A1 (es) Formulaciones liposómicas de compuestos de ácido borónico
CL2009000882A1 (es) Un compuesto n-(4-cloro-3-(piridin-2-il)fenil)-4-(2-hidroxi-2-metilpropilsulfonil)-2-metilbenzamida, inhibidor de la via de señalización hedgehog; composición farmacéutica que comprende a dicho compuesto; y su uso para tratar el cancer.
CR10987A (es) Composiciones dispersables en agua y los metodos para utilizar las composiciones dispersables en agua
ECSP099663A (es) Derivados y composiciones que comprenden isoindolina 4'-o-sustituida y métodos para utilizar la misma
NI201000179A (es) Pirimidin-5-carboxamidas sustituidas 281
UY32187A (es) Composiciones farmaceuticas topicas
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
MX2009007389A (es) Composiciones paras el cuidado oral que comprende extracto de hippophae.
AR066914A1 (es) Productos extruidos con enmascaramiento del sabor mejorado
AR062784A1 (es) Tratmiento de los vertigos con acetil -l- leucina
CO6260057A2 (es) Formulaciones de liposomas de compuestos de acido boronico
AR063894A1 (es) Uso de un acido indazolmetoxialcanoico para preparar una composicion farmaceutica
UY32618A (es) Combinación antitumoral que comprende ave8062 y sorafenib
UY31000A1 (es) Oxoisoxazoles como inhibidores de lipasas y fosfolipasas
ES2191643T3 (es) Chalcona-cumarinas.
PA8581701A1 (es) Derivados de indolilo